
Roger Owens
1.1K posts

Roger Owens
@rogerrowens
Ohio born & raised, now loving Dallas! Medical Device Space for 25 years. Love of Family, Friends, Work, Soccer, Cycling, Running, and enjoying the Outdoors!
Dallas, TX Katılım Mayıs 2015
209 Takip Edilen216 Takipçiler
Roger Owens retweetledi

HFpEF doesn’t always present the same way, especially in women. Variability in presentation and symptom overlap can make identification more challenging. Dr. @carinehamo shares key insights in the clip here: hubs.la/Q04bZLZC0
#HFpEF #HeartFailure #Echocardiography #WomensHealth #AIinHealthcare
English
Roger Owens retweetledi

From a single apical four-chamber (A4C) view to AI-driven insights.
Ultromics’ EchoGo® platform analyzes a routine A4C clip to support detection of HFpEF and Cardiac Amyloidosis—integrating seamlessly into existing echocardiography workflows. EchoGo® returns results in under 20 minutes to augment clinical decision-making and help guide patients along the appropriate care pathway. Want to learn more? Schedule a demo using the link below.
🔗 hubs.la/Q04bsGhP0
#AiInsights #ClinicalInnovation #HFpEF #ATTRCM
English
Roger Owens retweetledi

In our Febrary webinar, we explored gender disparities in heart failure and the role AI may play in reducing bias and supporting early detection. Moderator and speaker Dr. Sangita Sudharshan opened the discussion by sharing key insights on heart failure and its impact on women. Hear more in the clip below.
🎥 hubs.la/Q049Y9tk0
#ClinicalInnovation #HFpEF #HeartFailure #AiInsights
English
Roger Owens retweetledi

Hear our latest research tomorrow at #ACC26 as Ultromics’ Jodie Koep, Phd, presents: AI Prediction of ATTR Cardiac Amyloidosis Using Echocardiograms—Clinical Utility in the Case of Equivocal Diagnostic Testing
📢 Jodie Koep, MD
🗓️ Monday, March 30 | ⏰ 11:00 AM – 12:00 PM
📍 Hall E, Session 1564
We look forward to sharing how AI is being applied within echocardiography to support detection of cardiac amyloidosis in challenging diagnostic cases.
#ClinicalInnovation #ATTRCM #CardiacAmyloidosis
English
Roger Owens retweetledi

Attending #ACC26? Stop by booth 547 to connect with our team and learn how Ultromics’ clinically validated AI analyzes routine echocardiograms to support early detection of complex cardiac diseases, including HFpEF and Cardiac Amyloidosis.
#ClinicalInnovation #HFpEF #ATTRCM #AIinHealthcare

English
Roger Owens retweetledi

💡 #ACC26: @pattypellikka on the use of AI to support detection of Cardiac Amyloidosis. ATTR-CM remains underrecognized with high morbidity and mortality—highlighting the importance of identifying patients earlier.
Stop by booth 547 to hear more about how EchoGo® Heart Failure and EchoGo® Amyloidosis are being implemented to support early detection.
#ClinicalInnovation #ATTRCM #AmyloidAwareness #AIinHealthcare




English
Roger Owens retweetledi

We’re proud to share that Ultromics' own Jodie Koep, PHD, will be presenting new research at #ACC26.
AI Prediction of ATTR Cardiac Amyloidosis Using Echocardiograms: Clinical Utility in the Case of Equivocal Diagnostic Testing
🗓️ Monday March 30, from 11am-12pm
📍 Hall E, Session 1564
#CardiacAmyloidosis #ATTRCM #AmyloidosisAwarenessMonth #AmyloidosisAwareness #Echocardiography #ClinicalInnovation #AIinCardiology
English

From Missed Signals to Actionable Insight: The Next Phase of AI in Heart Failure Care | UPMC Enterprises: enterprises.upmc.com/resources/insi…
English
Roger Owens retweetledi

See you at #ACC26! Members of our commercial team will be on site and look forward to connecting. Stop by booth #547 to learn how EchoGo® supports detection of HFpEF and Cardiac Amyloidosis within routine echocardiography.
#HFpEF #CardiacAmyloidosis #ATTRCM #MedTech #DigitalHealth #AIinHealthcare

English
Roger Owens retweetledi

🚨Now available on the Verse: Women and Heart Failure: How AI can help close the gap in disease detection? Explore the discussion and hear directly from our expert speakers: hubs.la/Q047MHl-0
#ClinicalInnovation #TheVerse #HFpEF #CardiacAmyloidosis #ATTRCM #AIinHealthcare #AmyloidosisAwareness
English
Roger Owens retweetledi

Roger Owens retweetledi

Did you know it’s Amyloidosis Awareness Month? In our recent webinar, Dr. @SarswatNitasha spoke on cardiac amyloidosis detection in women—highlighting the diagnostic complexities, differences in presentation, and persistent gaps in research and recognition.
Improving awareness and recognition of cardiac amyloidosis is critical to supporting timely clinical consideration. Visit youtu.be/EFMQxtq2XrUto learn more!
#CardiacAmyloidosis #ATTRCM #AmyloidosisAwarenessMonth #AmyloidosisAwareness #Echocardiography #ClinicalInnovation #AIinCardiology

YouTube
English
Roger Owens retweetledi

Patient care is always top of mind at Ultromics. Our mission is to support clinicians in detecting complex cardiac disease early and guiding patients toward the appropriate care pathways sooner. Dr. Faizi Jamal shares how implementing EchoGo® has influenced care within the echocardiography workflow at City of Hope Comprehensive Cancer Center. Hear more about his insights using the links below.
📖 hubs.la/Q046M28Y0
🎥 hubs.la/Q046M39H0
#AIinCardiology #HeartFailure #HFpEF #CardiacAmyloidosis #ATTRCM #Echocardiography #ClinicalInnovation
English
Roger Owens retweetledi

"When I say care has improved as a result, that’s what I mean—we are providing information that prompts people to intervene."
In our latest article, Dr. Faizi Jamal shares insights on his initial goals for implementing EchoGo® and the clinical utility and impact he has observed. Visit the links below to learn more.
📖 ultromics.com/the-verse/putt…
🎥 youtube.com/watch?v=yw4_OZ…

YouTube


English
Roger Owens retweetledi

“Progress doesn’t happen without change, and that requires being open to it and patient—but also persistent.”
Learn more about how Dr. Faizi Jamal and his team at City of Hope Comprehensive Cancer Center have integrated EchoGo® into their daily echocardiography workflow. Read the full interview or watch the segment on implementation using the links below.
📖 hubs.la/Q046dCHm0
🎥 hubs.la/Q046dLV00
#AIinCardiology #HeartFailure #HFpEF #CardiacAmyloidosis #ATTRCM #Echocardiography #ClinicalInnovation
English

Looking forward to seeing our customers and colleagues at ACC
Ultromics@ultromics
Ultromics is headed to New Orleans for #ACC26! If you’re attending, we’d love to connect and share how EchoGo®, powered by AI, is being implemented in echocardiography workflows to support the detection of complex cardiac diseases, including HFpEF and Cardiac Amyloidosis.
English
Roger Owens retweetledi

📢We are proud to introduce The Verse — Ultromics' destination for new use cases and insights in the AI and Echo universe. Featuring trusted clinician voices, The Verse highlights how EchoGo® is being implemented in practice, showcasing operational utility, clinical credibility, and real-world impact.
Hear from the voices shaping how AI is being applied to routine echocardiography. Visit hubs.la/Q045VYXc0.
English
Roger Owens retweetledi

We sat down with Dr. Faizi Jamal to discuss the clinical impact of EchoGo® Heart Failure at City of Hope Comprehensive Cancer Center. Hear more about how EchoGo® is being integrated into practice and supporting clinical decision-making by reading the full interview or watching a segment of the interview through the links below.
🔗Click to Read: hubs.la/Q045ryL50
🎥 Click to Watch: hubs.la/Q045rHGB0
#EchoGo #AIinCardiology #HeartFailure #HFpEF #Echocardiography #ClinicalInnovation
English
Roger Owens retweetledi

Ultromics is on-site at #THT2026! Stop by Booth 18 to connect with our team and learn more about how Ultromics is applying AI to routine echocardiography to support early detection of complex cardiac diseases — including HFpEF and Cardiac Amyloidosis.
#EchoGo #HealthcareInnovation #AIinHealthcare #HFpEF #CardiacAmyloidosis #ATTRCM
English